ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Beam Therapeutics Spotlights CRISPR 2.0 with Precise Gene Editor, $87M – Xconomy

Continue reading

2018-05-14 Michael Zand NEWS

David Liu launches Beam Therapeutics to treat genetic diseases … – Chemical & Engineering News


Xconomy

Beam Therapeutics Spotlights CRISPR 2.0 with Precise Gene Editor, $87M
Xconomy
Xconomy Boston —. The founders of CRISPR-Cas9 startup Editas Medicine have gotten a jump on the next version of CRISPR gene editing. Scientists from Harvard University, Massachusetts General Hospital, and the Broad Institute are behind Beam …
Feng Zhang’s base-editing CRISPR startup officially launches with $87MFierceBiotech
A pencil, not a pair of scissors: CRISPR pioneers’ new company bets on base editing to cure diseaseSTAT
CRISPR trailblazers Zhang, Liu and Joung join forces to launch Beam with $87M and cutting-edge gene-editing techEndpoints News
MIT Technology Review –Financial Times –Business Insider
all 9 news articles »
Continue reading

2018-05-14 Michael Zand NEWS

A pencil, not a pair of scissors: CRISPR pioneers’ new company bets on base editing to cure disease – STAT


Chemical & Engineering News

David Liu launches Beam Therapeutics to treat genetic diseases …
Chemical & Engineering News
Beam CEO John Evans and the firm’s three cofounders, David Liu, Keith Joung, and Feng Zhang. When David R. Liu debuted his base editors, a modified form …
Beam Therapeutics lasers in on $87m series A · Articles · Global …Global University Venturing

all 2 news articles »

Continue reading

2018-05-14 Michael Zand NEWS

Beam Therapeutics launched to develop Harvard base editing technology toward precision genetic medicines – Harvard Office of Technology Development

Harvard Office of Technology DevelopmentBeam Therapeutics launched to develop Harvard base editing technology toward precision genetic medicinesHarvard Office of Technology DevelopmentGenome editing technologies using the CRISPR platform in combination… Continue reading

2018-05-14 Michael Zand NEWS

Feng Zhang’s base-editing CRISPR startup officially launches with $87M – FierceBiotech


STAT

A pencil, not a pair of scissors: CRISPR pioneers’ new company bets on base editing to cure disease
STAT
onths after its dozen scientists began working in secret on what’s been called “the most clever CRISPR gadget” so far, the latest company hoping to deploy genome-editing to cure diseases came out of stealth mode on Monday. Beam Therapeutics, which …

Continue reading

2018-05-14 Michael Zand NEWS

Beam Therapeutics receives Harvard license – Harvard Gazette

Harvard GazetteBeam Therapeutics receives Harvard licenseHarvard GazetteGenome editing technologies using the CRISPR platform in combination with enzymes like Cas9 and Cpf1 have shown great promise for adjusting genes through insertions or deletions of… Continue reading

2018-05-14 Michael Zand NEWS

Synthetic Biology Market Research Report: Know Market Dynamics, Opportunities and Risks 2025 – Expert Consulting

DailyCommerceNewsSynthetic Biology Market Research Report: Know Market Dynamics, Opportunities and Risks 2025Expert ConsultingSummary. The Synthetic Biology Market 2018 report is elaborated study of overall Synthetic Biology market together with introd… Continue reading

2018-05-14 Michael Zand NEWS

Synthetic Biology Market by Key Players, Types, Applications and Regions (USA, Europe, Japan, China, India, South … – The Truth Today

Synthetic Biology Market by Key Players, Types, Applications and Regions (USA, Europe, Japan, China, India, South …The Truth TodaySynthetic Biology Market focuses on the World market, in perspective of manufacturers, Regions, types and applications. … Continue reading

2018-05-14 Michael Zand NEWS
  • 1
  • …
  • 109
  • 110
  • 111
  • 112
  • 113
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

FierceBiotech

Feng Zhang’s base-editing CRISPR startup officially launches with $87M
FierceBiotech
Feng Zhang’s latest CRISPR company, Beam Therapeutics officially came out of stealth Monday, with $87 million in series A funding and a mission to develop “precision genetic medicines” that use CRISPR technology to edit just one nucleotide base, …
CRISPR trailblazers Zhang, Liu and Joung join forces to launch Beam with $87M and cutting-edge gene-editing techEndpoints News
Harvard and MIT launch gene editing companyFinancial Times
A startup that wants to make treatments that edit single letters in our DNA just raised $87 millionBusiness Insider
Business Wire (press release) –Harvard Gazette
all 6 news articles »